Brief Cognitive Behavioral Therapy Replication Trial

Status Enrolling by invitation

Clinical Trial Summary

The overall goal for the proposed project is to test the effectiveness of BCBT for the prevention of suicide attempts in a sample of treatment-seeking U.S. military personnel and veterans. The standard null hypothesis will involve tests conducted comparing improvement following BCBT (treatment duration of 12 weeks) to Person-Centered Therapy (PCT). The primary outcome comparisons will include direct markers of suicidality (i.e. suicide, suicide attempts). Secondary outcomes will be suicide ideation and indicators of psychiatric distress (e.g., depression, hopelessness). We also aim to assess several hypothesized psychological and neurocognitive mediators of treatment effects (e.g., wish to live, attentional bias, emotion regulation). Participants will be followed for 2 years posttreatment by independent evaluators blind to treatment condition.

Clinical Trial Description

The number of suicides by military personnel and veterans has steadily increased during the past few decades and remains elevated. Previous research conducted with active duty Army personnel supports the superiority of BCBT and its components over treatment as usual for the reduction of suicide attempts. Additional research is needed to determine if these effects are generalizable to military personnel and veterans more broadly and to confirm hypothesized mechanisms of action. Reference to "active duty" refers to U.S. military service members that have been activated and deployed as a part of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) in accordance with federal orders under Title 10 or 32, United States Code. Reference to "veteran" refers to any person who has served in the U.S. military at any time, regardless of Branch, Component, era, or discharge status. Specific Aim 1:To replicate previous findings supporting the efficacy of BCBT for the prevention of suicide attempts among military personnel and veterans (regardless of Axis I or II diagnosis). The standard null hypothesis will involve tests conducted comparing improvement following BCBT to Present-Centered Therapy (PCT) Specific Aim 2: To identify cognitive-affective mediators of BCBT's effects on risk for suicide attempt. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03769259
Study type	Interventional
Source	University of Utah
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	January 22, 2020
Completion date	August 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05334381` - Navigating Mental Health Treatment for Black Youth	N/A
Recruiting	`NCT04653337` - Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression	Phase 2
Terminated	`NCT04254809` - Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts	N/A
Recruiting	`NCT05848089` - Real-time Intervention for Suicide Risk Reduction	N/A
Recruiting	`NCT06322199` - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Completed	`NCT05280756` - Home-based tDCS for Prevention of Suicidal Ideation	N/A
Not yet recruiting	`NCT06454136` - Pilot Trial of Mobile Technology for Adolescent Suicidality	N/A
Completed	`NCT01944293` - Ketamine for Suicidality in Bipolar Depression	Phase 1/Phase 2
Completed	`NCT02021344` - Mental Health First Aid for College Students	N/A
Not yet recruiting	`NCT04686162` - Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy	N/A
Recruiting	`NCT05377177` - Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI	N/A
Completed	`NCT05580757` - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting	`NCT05925322` - Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality	N/A
Not yet recruiting	`NCT05427734` - Treating Drivers of Suicide Using Jaspr Health	N/A
Recruiting	`NCT04112368` - Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach	Phase 4
Completed	`NCT04026308` - Written vs Electronic Safety Planning Study	N/A
Recruiting	`NCT05537376` - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness	N/A
Not yet recruiting	`NCT06311591` - Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B	N/A
Recruiting	`NCT05894980` - How to Reduce Suicidal Thoughts and Impulsivity in Depression	N/A
Not yet recruiting	`NCT05860257` - Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.